Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model.
Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model. Mol Cancer Ther. 2013 Jun; 12(6):1140-50.
View in:
PubMed
subject areas
Animals
Apoptosis
bcl-X Protein
Boronic Acids
Bortezomib
Cell Line, Tumor
Cell Proliferation
Drug Resistance, Neoplasm
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Genes, myc
Histone Deacetylase Inhibitors
Histone Deacetylases
Humans
Mice
Mice, Transgenic
Multiple Myeloma
Pyrazines
authors with profiles
Nathan Graeme Dolloff